Others, interestingly, were implicated in tumor growth [e.g., YES1, PML; (81, 82)] and a range of other health-related outcomes [e.g., SNX13 and CCHCR1; heart failure, skin disease; (83, 84)]. This evidence concerns the gene YES1 and neoplasm.